Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMS is the largest pharmaceutical company in Brazil and a leader in the Latin American market, specializing in the development, manufacturing, and commercialization of a vast portfolio of generic and branded medicines. The company operates across multiple segments, including prescription drugs, over-the-counter (OTC) products, and a significant line of phytotherapeutic (herbal) medicines often referred to under its natural health initiatives. EMS maintains state-of-the-art manufacturing facilities and a robust research and development infrastructure focused on expanding access to affordable healthcare. With a strong presence in both domestic and international markets, EMS continues to innovate through strategic partnerships and the development of complex generics and biosimilars.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMS Herbals.